Bioamber Inc.  (BIOA)
Other Ticker:  
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00

 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 52
 Employees 86
 Revenues (TTM) (Millions $) 15
 Net Income (TTM) (Millions $) -102
 Cash Flow (TTM) (Millions $) -12
 Capital Exp. (TTM) (Millions $) 1

Bioamber Inc.


Customers Net Income grew by BIOA's Customers Net Profit Margin grew to

42.42 %

7.54 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
ASH        1.58% 
CC        4.96% 
CE        1.64% 
HUN        1.1% 
LYB   -3.46%    
PPG        0.93% 
• View Complete Report

Rex American Resources Corporation

Rex American Resources Corporation Soars to Break-Even Point with Impressive Revenue Growth

Rex American Resources Corporation (NYSE: REX) is a leading ethanol company that recently announced its financial results for the third quarter of fiscal year 2023. The company reached a break-even point with a moderate revenue increase of 0.364% to $221.08 million compared to the same quarter a year ago. In comparison to the preceding quarter, revenue surged by 4.294% from $211.98 million.
One of the significant highlights of the financial report is the significant increase in net income. In the August to October 31, 2023 fiscal period, net income reached $31.642 million, representing a substantial increase of 546.02% from net earnings of $4.898 million reported in the same period a year ago. This growth in net income showcases the company's ability to generate higher profits over time.

Next Chemx Corporation

Next Chemx Corporation: Battling Unexpected Challenges with a $0.4 Million Operating Loss in Q3

Reflections on Next Chemx Corporation's Financial Results: A Rocky Third Quarter
As a veteran financial analyst, dissecting and interpreting financial results is my bread and butter. Today, I bring you my insights into the recently released financial results of Next Chemx Corporation, a leading chemical manufacturing company. Brace yourselves, because this company has faced some unexpected bumps on its path to success.
Let's begin with the earnings cycle of fiscal July to September 30, 2023. Stockholders had not anticipated any adjustments during this period, but they were taken aback by the company's operating loss of $-0.403435 million. This came as a surprise, especially considering the business had not reported any revenue figures yet.

Nano Magic Inc

Nano Magic Inc faces fiscal challenges, but potential stability lies ahead

Nano Magic Inc, a Chemical Manufacturing company, has recently released its financial results for the time-frame closing September 30, 2023. While the numbers reflect a challenging period for the company, it is crucial to analyze the implications of these results on Nano Magic's future performance.
Losses Widen but Stability May Lie Ahead:
Nano Magic Inc has incurred a loss of $-0.06 per share, compared to $-0.05 in the previous year and the prior quarter. While the continuously increasing losses are concerning, the fact that the losses did not further widen from the prior quarter may indicate a possible stabilization of the company's financials.

Cardinal Ethanol Llc

Chemical Manufacturer Battles Decreased Revenue in Q4 2023: Adjusting Strategies for Success

Cardinal Ethanol LLC, a leading chemical manufacturing company, recently released its financial report for the fourth quarter of 2023. While the company experienced a decline in revenue, its earnings per share (EPS) and income per share showed significant growth. Additionally, Cardinal Ethanol highlighted improvements in profit margins and reductions in inventories. This article will delve into the key figures and provide insights into the company's overall performance.
Impressive Earnings Growth:
During the financial fourth quarter of 2023, Cardinal Ethanol witnessed an outstanding increase in EPS, which soared by a remarkable 144% to $1,788.86 per share from $733.13 per share the previous year. Furthermore, income per share experienced substantial growth, rising by 82.91% from $978.00 per share in the preceding reporting period. These figures signify the company's ability to generate higher profits on a per-share basis, reflecting strong financial performance.

Kraig Biocraft Laboratories Inc

Revolutionizing the Industry: Chemical Manufacturing Giant Achieves Extraordinary $0.049196 Million Revenue in Q3 2023 Financial Report

Kraig Biocraft Laboratories Inc (KBLB) is a biotechnology company that specializes in genetic engineering and developing innovative materials using spider silk. With a focus on commercializing spider silk technologies, the company aims to create stronger and more versatile materials for various industrial applications.
In the fiscal time-frame from July to September 2023, Kraig Biocraft Laboratories Inc reported a revenue of $0.049196 million. While this might seem relatively low, it is noteworthy considering the company's focus on research and development, which often generates revenue in the later stages of product development.


Bioamber's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Bioamber does not provide revenue guidance.

Earnings Outlook
Bioamber Inc. does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com